The role of inhaled corticosteroids in the management of acute asthma

European Respiratory Journal

Volumn 30, Issue 6, 2007, Pages 1035-1037

  Rowe, B H ^a,b   Vethanayagam, D ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

^b UNIVERSITY OF ALBERTA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CORTICOSTEROID; FLUTICASONE; LEUKOTRIENE RECEPTOR BLOCKING AGENT; PREDNISONE;

ASTHMA; COMBINATION CHEMOTHERAPY; DISEASE CONTROL; DISEASE COURSE; DISEASE EXACERBATION; DISEASE SEVERITY; EDITORIAL; EOSINOPHIL COUNT; HEALTH CARE ACCESS; HEALTH CARE PLANNING; HOSPITAL ADMISSION; HUMAN; LUNG FUNCTION; LUNG FUNCTION TEST; MONOTHERAPY; PATHOPHYSIOLOGY; PATIENT CARE; PRIORITY JOURNAL; QUALITY OF LIFE; RISK ASSESSMENT; RISK FACTOR; TREATMENT OUTCOME;

ADMINISTRATION, INHALATION; ADRENAL CORTEX HORMONES; ASTHMA; BIOLOGICAL MARKERS; HUMANS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; TREATMENT OUTCOME;

EID: 38849142621     PISSN: 09031936     EISSN: None     Source Type: Journal    
DOI: 10.1183/09031936.00119907     Document Type: Editorial

References (32)

1. Mannino DM, Homa DM, Pertowski CA, et al. Surveillance for asthma - United States, 1960-1995. MMWR CDC Surveill Summ 1998; 47: 1-28.
2. Louis R, Lau LCK, Bron AO, Roldaan AC, Radermecker M, Djukanovic R. The relationship between airways inflammation and asthma severity. Am J Respir Crit Care Med 2000; 161: 9-16.
3. Weiss KB, Sullivan SD. The health economics of asthma and rhinitis. I. Assessing the economic impact. J Allergy Clin Immun 2001; 107: 3-8.
4. Serra-Batlles J, Plaza V, Morejon E, Comella A, Brugues J. Costs of asthma according to the degree of severity. Eur Respir J 1998; 12: 1322-1326.
5. Krahn MD, Berka C, Langlois P, Detsky AS. Direct and indirect costs of asthma in Canada. CMAJ 1996; 154: 821-831.
6. Tsuyuki RT, Sin DD, Sharpe HM, et al. Management of asthma among community-based primary care physicians. J Asthma 2005; 42: 163-167.
7. Chapman KR, Ernst P, Grenville A, Dewland P, Zimmerman S. Control of asthma in Canada: failure to achieve guideline targets. Can Respir J 2001; 8, Suppl. A, 35A-40A.
8. Mannino DM, Homa DM, Akinbami LJ, Moorman JE, Gwynn C, Redd SC. Surveillance for Asthma - United States, 1980-1999. MMWR Surveill Summ 2002; 51: 1-13.
9. Cates CJ, Crilly JA, Rowe BH. Holding chambers (spacers) versus nebulisers for β-agonist treatment of acute asthma. Cochrane Database of Syst Rev 2006; 2: CD000052.
10. Stoodley RG, Aaron SD, Dales RE. The role of ipratropium bromide in the emergency management of acute asthma exacerbation: a meta-analysis of randomized clinical trials. Ann Emerg Med 1999; 34: 8-18.
11. Rowe BH, Spooner C, Ducharme FM, Bretzlaff JA, Bota GW. Early emergency department treatment of acute asthma with systemic corticosteroids. Cochrane Database Syst Rev 2001; 1: CD002178.
12. Rowe BH, Bretzlaff JA, Bourdon C, Bota GW, Camargo CA Jr. Magnesium sulfate for treating exacerbations of acute asthma in the emergency department. Cochrane Database Syst Rev 2000; 1: CD001490.
13. Ram FSF, Wellington SR, Rowe BH, Wedzicha JA. Noninvasive positive pressure ventilation for treatment of respiratory failure due to severe acute exacerbations of asthma. Cochrane Database Syst Rev 2005; 1: CD004360.
14. Blitz M, Blitz S, Beasely R, et al. Inhaled magnesium sulfate in the treatment of acute asthma. Cochrane Database Syst Rev 2005; 4: CD003898.
15. Rodrigo G, Pollack C, Rodrigo C, Rowe BH. Heliox for nonintubated acute asthma patients. Cochrane Database Syst Rev 2006; 4: CD002884.
16. Travers A, Jones A, Camargo CA Jr, Rowe BH. Intravenous β2-agonists for acute asthma in the emergency department. Cochrane Database Syst Rev 2001; 1: CD002988.
17. Parameswaran K, Belda J, Rowe BH. Addition of intravenous aminophylline to β2-agonists in adults with acute asthma. Cochrane Database Syst Rev 2000; 4: CD002742.
18. Graham VAL, Lasserson T, Rowe BH. Antibiotics for acute asthma. Cochrane Database Syst Rev 2001; 2: CD002741.
19. Chan L, O'Malley BW. Steroid hormone action: recent advances. Ann Intern Med 1978; 89: 694-701.
20. Edmonds ML, Camargo CA Jr, Pollack CV, Rowe BH. Early use of inhaled corticosteroids in the emergency department treatment of acute asthma. Cochrane Database of Syst Rev 2003; 3: CD002308.
21. Belda J, Margarit G, Martinez C, et al. Anti-inflammatory effects of high-dose inhaled fluticasone versus oral prednisone in asthma exacerbations. Eur Respir J 2007; 30: 1143-1149.
22. Rowe BH, Bota GW, Fabris L, Therrien SA, Milner RA, Jacono J. Inhaled budesonide in addition to oral corticosteroids to prevent relapse following discharge from the emergency department: a randomized controlled trial. JAMA 1999; 281: 2119-2126.
23. Pizzichini E, Pizzichini MM, Efthimiadis A, et al. Indices of airway inflammation in induced sputum: reproducibility and validity of cell and fluid-phase measurements. Am J Respir Crit Care Med 1996; 154: 308-317.
24. Jayaram L, Pizzichini MM, Cook RJ, et al. Determining asthma treatment by monitoring sputum cell counts: effect on exacerbations. Eur Respir J 2006; 27: 483-494.
25. Simpson JL, Scott R, Boyle MJ, Gibson PG. Inflammatory subtypes in asthma: assessment and identification using induced sputum. Respirology 2006; 11: 54-61.
26. Green RH, Brightling CE, McKenna S, et al. Asthma exacerbations and sputum eosinophil counts: a randomised controlled trial. Lancet 2002; 360: 1715-1721.
27. Klassen TP, Feldman ME, Watters LK, Sutcliffe T, Rowe PC. Nebulized budesonide for children with mild-to-moderate croup. N Engl J Med 1994; 331: 285-289.
28. Rowe BH, Spooner CH, Ducharme FM, Bretzlaff JA, Bota GW. Corticosteroids for preventing relapses following acute exacerbations of asthma. Cochrane Database Syst Rev 2001; 1: CD000195.
29. Edmonds ML, Camargo CA Jr, Brenner B, Rowe BH. Inhaled steroids in acute asthma following emergency department discharge. Cochrane Database of Syst Rev 2000; 3: CD002316.
30. Rowe BH, Wong E, Blitz S, et al. Adding long-acting bagonists to inhaled corticosteroids after discharge from the emergency department for acute asthma: a randomized controlled trial. Acad Emerg Med 2007; (In Press).
31. Persson CC. The role of microvascular permeability in the pathogenesis of asthma. Eur Journal Respir Dis Suppl 1986; 144: S190-S216.
32. Wedde-Beer K, Hu C, Rodriguez MM, Piedimonte G. Leukotrienes mediate neurogenic inflammation in lungs of young rats infected with respiratory syncytial virus. Am J Physiol 2002; 282: L1143-L1150.